Interestingly, ATXN3 appears to positively regulate PD-L1 expression at the transcriptional level, since real-time reverse transcription PCR analysis confirmed that Atxn3 targeting dramatically inhibited Cd274 mRNA expression in both LLC1 and B16 mouse cancer cells (Figure 1, J–M). This evidence concerns the gene ATXN3 and cancer.